Clinical Laboratory Services Market Forecast 2018 with : Kalila Medical (Abbott Laboratories), ARUP Laboratories, Charles River Laboratories, Fresenius Medical Care, Fullerton Health, Genoptix, Inc

U.S. clinical laboratory services market accounted for 76.6% regional market share in 2017. Presence of leading industry players providing advanced test solutions coupled with growing elderly population base that is more prone to acquire chronic diseases will augment market growth. Moreover, escalating prevalence of lifestyle associated diseases should further boost industry growth during forthcoming years.

Germany clinical laboratory services market held USD 11.0 billion in 2017. Rising cardiovascular diseases, infectious diseases thus, increasing patient pool and demand for clinical laboratory examinations should foster business growth in the country.
India clinical laboratory services market is anticipated to grow lucratively at 9.2% over the forecast timeframe. Surging demand for early disease diagnosis by many patients and availability of advanced testing equipment will upsurge market size.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/807

Growing prevalence of target diseases including diabetes, liver & kidney disorders, cardiovascular, and blood disorders will boost the market growth. according to WHO May 2017 data, cardiovascular diseases (CVDs) are major cause of death globally. In addition to this, in 2015 an estimated nearly 17.7 million individuals expired due to CVDs, that represents around 31% of global deaths. Individuals with one or more disease conditions are at more risk and require early detection as well as management of disease that should contribute to clinical laboratory services industry growth over the forecast period.

Rising awareness among people and ailment management being possible if disease state is detected earlier should foster market growth. Availability of probable cure coupled with technological advancements will increase demand for clinical tests. Moreover, emerging infectious ailments have potential to cause substantial mortality, morbidity, and economic damage. Efforts undertaken for prevention of emerging infectious ailments will further drive the global market growth during the forecast timeline.

Clinical laboratory services require safe working environment and thus regulations are stringent that will hamper market growth. Furthermore, inadequate reimbursements and diagnostic lab test rates that vary widely should restrain clinical laboratory services industry growth over the coming years.

Browse Full Report Details @ https://www.gminsights.com/industry-analysis/clinical-laboratory-services-market

Clinical chemistry by test type segment accounted for 46.3% market share in 2017. High demand for clinical chemistry testing coupled with wide-ranging diagnosis of several diseases that can be covered by chemistry assessments will drive segmental growth. Additionally, clinical advances for diagnosis methods including flow cytometry and mass spectrometry should offer immense segmental growth opportunities in foreseeable future.

Human & tumor genetics by test type segment held USD 47.1 billion in 2017, due to technological advances in genetics that should influence laboratory testing segmental growth. Moreover, accessibility of genetic testing techniques that are feasible to complete even in small size labs will further augment demand for human and tumor genetic tests.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
 Kalila Medical (Abbott Laboratories)
 ARUP Laboratories
 Charles River Laboratories
 Fresenius Medical Care
 Fullerton Health Genoptix, Inc
 Litholink / Laboratory Corporation of America
 LabCorp
 NeoGenomics Laboratories
 Clarient
 OPKO Health, Inc
 BioReference Laboratories
 QIAGEN
 Quest Diagnostics
 Sanofi Genzyme
 Siemens
 Sonic Healthcare
 SYNLAB

Hospital-based laboratories service provider segment held USD 126.8 billion in 2017, owing to surging demand for early disease detection coupled with emerging infectious ailments. Hospital-based laboratories provide comprehensive services from core testing, specialty testing to lab management services that should drive segmental growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/807

Stand-alone laboratories segment will grow at 7.1% over the coming years as a result of increasing initiatives by industry players to set laboratories along with introduction of innovative solutions. This includes launch of diagnostic platforms that provide efficient detection of diseases that will foster clinical laboratory services market growth.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: http://solutionrocket.com

This release was published on openPR.